F I S - FABBRICA ITALIANA SINTETICI S P A has a total of 30 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are FIS FABBRICA ITALIANA SINTETICI SPA, SHANGHAI INST ORGANIC CHEMISTRY CAS and ENANTIA S L.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | China | 4 | |
#4 | Canada | 3 | |
#5 | United States | 2 | |
#6 | Hungary | 1 | |
#7 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Chemical engineering | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Organic chemistry methods | |
#3 | Therapeutic chemical compounds | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Chemical or physical processes | |
#6 | Microorganisms | |
#7 | Fermentation | |
#8 | Enzymes | |
#9 | Special acyclic compounds | |
#10 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Tesson Nicolas | 6 |
#2 | De Lucchi Ottorino | 6 |
#3 | Fogal Stefano | 5 |
#4 | Motterle Riccardo | 5 |
#5 | Galvagni Marco | 5 |
#6 | Stabile Paolo | 5 |
#7 | Bertolazzi Moreno | 4 |
#8 | Caruana Lorenzo | 4 |
#9 | Pontini Marta | 4 |
#10 | Faccin Nicola | 4 |
Publication | Filing date | Title |
---|---|---|
CA2989364A1 | Process for the preparation of enclomiphene citrate having needle shaped crystal habit. | |
EP3159343A1 | Improved process for the preparation of triazole and salt thereof | |
EP3109236A1 | Scalable process for the preparation of sorafenib tosylate ethanol solvate and sorafenib tosylate form iii | |
EP3064495A1 | Improved process for the preparation of optically pure esomeprazole | |
EP3098221A1 | Process for preparing apixaban form n-1 | |
EP2551265A1 | Novel process for the preparation of 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of etoricoxib. | |
EP2303856A2 | Process for the preparation of 3,4-dihydro-2h-thien[3,2-e]-1,2-thiazin-4-ol 1, 1-dioxide derivatives and intermediates |